11 insiders reported 27 Form 4 transactions for BiomX Inc. (PHGE) over the past 18 months (most recent 2026-03-18). Recent activity: Yeganeh Reuven (Director) Buy 450,000 shares, Yeganeh Reuven (Director) Sell 450,000 shares, Yeganeh Reuven (Director) Buy 530,000 shares, Yeganeh Reuven (Director) Sell 530,000 shares, Yeganeh Reuven (Director) Buy 300,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-18 | Yeganeh Reuven | Director | Buy | 450,000 | $900,000 |
| 2026-03-18 | Yeganeh Reuven | Director | Sell | 450,000 | $2.2M |
| 2026-03-18 | Yeganeh Reuven | Director | Buy | 530,000 | $1.1M |
| 2026-03-18 | Yeganeh Reuven | Director | Sell | 530,000 | $2.6M |
| 2026-03-13 | Yeganeh Reuven | Director | Buy | 300,000 | $600,000 |
| 2026-03-13 | Yeganeh Reuven | Director | Sell | 300,000 | $1.5M |
| 2026-03-13 | Yeganeh Reuven | Director | Buy | 370,000 | $740,000 |
| 2026-03-13 | Yeganeh Reuven | Director | Sell | 370,000 | $1.9M |
| 2025-04-21 | Solomon Jonathan Eitan | Chief Executive Officer | Buy | 126,748 | $0 |
| 2025-04-21 | Bassan Merav | Chief Development Officer | Buy | 79,597 | $0 |
| 2025-04-21 | Wolfson Marina | Chief Financial Officer | Buy | 68,545 | $0 |
| 2025-04-18 | Bassan Merav | Chief Development Officer | Buy | 79,597 | $0 |
| 2025-04-18 | Solomon Jonathan Eitan | Chief Executive Officer | Buy | 126,748 | $0 |
| 2025-04-18 | Wolfson Marina | Chief Financial Officer | Buy | 68,545 | $0 |
| 2025-03-04 | Cystic Fibrosis Foundation | Insider | Buy | 854,700 | $0 |
| 2025-03-03 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Director | Buy | 353,249 | $328,522 |
| 2025-03-03 | Flynn James E | Director | Buy | 353,249 | $328,522 |
| 2025-03-03 | Deerfield Mgmt HIF, L.P. | Director | Buy | 353,249 | $328,522 |
| 2025-03-03 | Deerfield Healthcare Innovations Fund II, L.P. | Director | Buy | 353,249 | $328,522 |
| 2025-03-03 | Deerfield Private Design Fund V, L.P. | Director | Buy | 353,249 | $328,522 |
| 2025-03-03 | Deerfield Mgmt V, L.P. | Director | Buy | 353,249 | $328,522 |
| 2025-03-03 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Director | Buy | 353,249 | $328,522 |
| 2025-03-03 | Flynn James E | Director | Buy | 353,249 | $328,522 |
| 2025-03-03 | Deerfield Mgmt HIF, L.P. | Director | Buy | 353,249 | $328,522 |
| 2025-03-03 | Deerfield Healthcare Innovations Fund II, L.P. | Director | Buy | 353,249 | $328,522 |
Source: SEC Form 4 filings · as of 2026-03-18